These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2439613)

  • 1. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
    Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
    J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
    Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
    J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
    Baumgartner JD; Heumann D; Calandra T; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
    Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
    de Jongh-Leuvenink J; Bouter AS; Marcelis JH; Schellekens J; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):148-51. PubMed ID: 2424754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria.
    Chaiyotwittayakun A; Burton JL; Weber PS; Kizilkaya K; Cardoso FF; Erskine RJ
    J Dairy Sci; 2004 Oct; 87(10):3375-85. PubMed ID: 15377616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.
    McCallus DE; Norcross NL
    Infect Immun; 1987 May; 55(5):1042-6. PubMed ID: 3552983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.
    Fenwick BW; Cullor JS; Osburn BI; Olander HJ
    Infect Immun; 1986 Aug; 53(2):298-304. PubMed ID: 3525407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting.
    de Jongh-Leuvenink J; Vreede RW; Marcelis JH; de Vos M; Verhoef J
    Infect Immun; 1985 Dec; 50(3):716-20. PubMed ID: 3905612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5.
    Dunn DL; Ferguson RM
    Surgery; 1982 Aug; 92(2):212-9. PubMed ID: 7048594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
    Mutharia LM; Crockford G; Bogard WC; Hancock RE
    Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of normal serum in the binding of lipopolysaccharide to IgG fractions from rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Warren HS; Glennon M; de Deckker FA; Tello D
    J Infect Dis; 1991 Jun; 163(6):1256-66. PubMed ID: 1709961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.